---
layout: post
title: "Peripheral Percutaneous Transluminal Angioplasty and Specialty Catheters-Premarket Notification (510(k)) Submissions; Guidance for Industry and Food and Drug Administration Staff; Availability"
date: 2026-02-05 18:55:13 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-07896
original_published: 2023-04-14 00:00:00 +0000
significance: 8.00
---

# Peripheral Percutaneous Transluminal Angioplasty and Specialty Catheters-Premarket Notification (510(k)) Submissions; Guidance for Industry and Food and Drug Administration Staff; Availability

**Published:** February 05, 2026 18:55 UTC
**Source:** Federal Register
**Original Published:** April 14, 2023 00:00 UTC
**Document Number:** 2023-07896

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled "Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters--Premarket Notification (510(k)) Submissions." FDA is issuing this final guidance document to provide recommendations for 510(k) submissions for peripheral percutaneous transluminal angioplasty (PTA) balloons and specialty catheters (e.g., infusion catheters, PTA balloon catheters for in-stent restenosis (ISR), scoring/cutting balloons).

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/04/14/2023-07896/peripheral-percutaneous-transluminal-angioplasty-and-specialty-catheters-premarket-notification-510k)
- API: https://www.federalregister.gov/api/v1/documents/2023-07896

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
